Compound Summary
e-64
Compound Information
e-64
Compound Name: | e-64 |
Compound CID: | 123985 |
Synonyms: | e-64 66701-25-5 E 64 Proteinase inhibitor E 64 UNII-R76F7856MV More... |
Iupac Name: | (2S,3S)-3-[[(2S)-1-[4-(diaminomethylideneamino)butylamino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylic acid |
InChI: | InChI=1S/C15H27N5O5/c1-8(2)7-9(20-13(22)10-11(25-10)14(23)24)12(21)18-5-3-4-6-19-15(16)17/h8-11H,3-7H2,1-2H3,(H,18,21)(H,20,22)(H,23,24)(H4,16,17,19)/t9-,10-,11-/m0/s1 |
InChIKey: | LTLYEAJONXGNFG-DCAQKATOSA-N |
Canonical Smiles: | CC(C)CC(C(=O)NCCCCN=C(N)N)NC(=O)C1C(O1)C(=O)O |
Isomeric Smiles: | CC(C)C[C@@H](C(=O)NCCCCN=C(N)N)NC(=O)[C@@H]1[C@H](O1)C(=O)O |
Molecular Weight: | 357.41 |
Molecular Formula: | C15H27N5O5 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
e-64
Molecular Weight: | 357.41 |
Molecular Formula: | C15H27N5O5 |
Hydrogen Bond Donor Count: | 5 |
Hydrogen Bond Acceptor Count: | 6 |
Rotatable Bond Count: | 11 |
Heavy Atom Count: | 25 |
Complexity: | 518 |
Synonyms
e-64
| e-64 | e-64 |
|---|---|
e-64 |
66701-25-5 |
E 64 |
Proteinase inhibitor E 64 |
UNII-R76F7856MV |
CHEMBL374508 |
CHEBI:30270 |
R76F7856MV |
E64 |
Thiol protease inhibitor |
(2S,3S)-3-(2S)-1-4-(diaminomethylideneamino)butylamino-4-methyl-1-oxopentan-2-ylcarbamoyloxirane-2-carboxylic acid |
3-(1S)-1-4-(aminoiminomethyl)aminobutylaminocarbonyl-3-methylbutylaminocarbonyl-(2S,3S)-oxiranecarboxylic acid |
E 64 (proteinase inhibitor) |
BRN 1405664 |
MFCD00080261 |
(2S,3S)-3-(((S)-1-((4-Guanidinobutyl)amino)-4-methyl-1-oxopentan-2-yl)carbamoyl)oxirane-2-carboxylic acid |
5-18-07-00006 (Beilstein Handbook Reference) |
SCHEMBL4740187 |
2-Oxiranecarboxylic acid, 3-(1S)-1-4-(aminoiminomethyl)aminobutylaminocarbonyl-3-methylbutylaminocarbonyl-, (2S,3S)- |
EX-A2284 |
BDBM50157741 |
ZINC13493525 |
(L-3-TRANS-CARBOXYOXIRANE-2-CARBONYL)-L-LEUCYLAGMATINE HEMIHYDRATE |
AKOS016007415 |
CCG-207844 |
CCG-208198 |
CS-4140 |
FD21944 |
NCGC00163544-01 |
NCGC00163544-09 |
(2S,3S)-3-(1S)-1-(4-guanidinobutylcarbamoyl)-3-methyl-butylcarbamoyloxirane-2-carboxylic acid |
HY-15282 |
Oxiranecarboxylic acid, 3-(((1-(((4-((aminoiminomethyl)amino)butyl)amino)carbonyl)-3-methylbutyl)amino)carbonyl)-, (2S-(2-alpha,3-beta(R*)))- |
Oxiranecarboxylic acid, 3-(((1-(((4-((aminoiminomethyl)amino)butyl)amino)carbonyl)-3-methylbutyl)amino)carbonyl)-, (2S-(2alpha,3beta(R*)))- |
C01341 |
E-0010 |
Q5321373 |
trans-epoxysuccinyl-l-leucylamido-(4-guanidino)butane |
(2S,3S)-3-((S)-1-(4-Guanidinobutylamino)-4-methyl-1-oxopentan-2-ylcarbamoyl)oxirane-2-carboxylic acid |
(2S,3S)-3-(N-{(S)-1-N-(4-guanidinobutyl)carbamoyl3-methylbutyl}carbamoyl)oxirane-2-carboxylic acid |
(2S,3S)-3-(1S)-1-4-(Aminoiminomethyl)aminobutylaminocarbonyl-3-methylbutylaminocarbonyl-2-oxiranecarboxylic acid |
3-1-4-(diaminomethylideneamino)butylamino-4-methyl-1-oxopentan-2-ylcarbamoyloxirane-2-carboxylic acid |
80408-29-3 |
Experimental Data
e-64
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -3.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
e-64
Statistics Data
e-64
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -3.000000000000000 | 1 | 1 |
Statistics Data Visualization
e-64
